| Literature DB >> 25147770 |
Natalia Petrenya1, Magritt Brustad2, Liliya Dobrodeeva3, Fatima Bichkaeva3, Gulnara Lutfalieva3, Marie Cooper4, Jon Øyvind Odland1.
Abstract
BACKGROUND: The prevalence of obesity and obesity-related conditions varies by population groups. Indigenous women of the circumpolar north are believed to be at high risk of obesity.Entities:
Keywords: Arctic; Nenets; Russians; body mass index; cardiometabolic risk; ethnicity; obesity; waist circumference; waist-to-hip ratio; women
Mesh:
Year: 2014 PMID: 25147770 PMCID: PMC4111876 DOI: 10.3402/ijch.v73.23859
Source DB: PubMed Journal: Int J Circumpolar Health ISSN: 1239-9736 Impact factor: 1.228
Characteristics of women by residence (n=225)a
| Characteristics | Arkhangelsk, N=132 | Nelmin-Nos, N=93 | p |
|---|---|---|---|
| Age (years), median (IQR) | 51 (38–55) | 46 (32–53) | 0.013 |
| Height (cm), mean (SD) | 161.6 (5.8) | 151.9 (6.7) | <0.001 |
| Weight (kg), GM (95% CI) | 71.3 (68.7–74.0) | 64.9 (61.9–67.8) | 0.001 |
| WC (cm), GM (95% CI) | 85.5 (83.4–87.9) | 85.7 (82.8–88.5) | 0.964 |
| Hip circumference (cm), GM (95% CI) | 106.2 (104.2–108.1) | 102.3 (100.0–104.7) | 0.014 |
| BMI (kg/m2), GM (95% CI) | 27.2 (26.2–28.1) | 28.6 (27.2–29.6) | 0.126 |
| Waist-to-hip circumference ratio (%), GM (95% CI) | 0.81 (0.79–0.82) | 0.84 (0.82–0.85) | 0.001 |
| BMI groups (kg/m2), n (%) | |||
| ≤29.9 | 80 (65.6) | 46 (57.5) | |
| ≥30 | 42 (34.4) | 34 (42.5) | 0.247 |
| WC groups (cm), n (%) | |||
| ≤87.9 | 60 (53.6) | 41 (54.7) | |
| ≥88 | 52 (46.4) | 34 (45.3) | 0.883 |
| WHR groups, n (%) | |||
| ≤0.84 | 79 (70.5) | 43 (58.1) | |
| ≥0.85 | 33 (29.5) | 31 (41.9) | 0.081 |
| TC≥5.1 mmol/L, n (%) | 88 (68.8) | 45 (48.9) | 0.003 |
| HDL-C<1.3 mmol/L, n (%) | 84 (68.3) | 59 (64.1) | 0.522 |
| HDL-C<1.0 mmol/L, n (%) | 37 (30.1) | 24 (39.3) | 0.520 |
| TG≥1.7 mmol/L, n (%) | 26 (20.3) | 13 (14.1) | 0.236 |
| Apo B/A-I ratio (%), GM (95% CI) | 1.0 (0.93–1.08) | 0.92 (0.85–1.01) | 0.175 |
| FG (mmol/L), GM (95% CI) | 4.9 (4.8–5.1) | 4.3 (4.2–4.5) | <0.001 |
| FG≥6.1 mmol/L, n (%) | 6 (4.7) | 5 (5.4) | 0.802 |
| FI (µU/ml), GM (95% CI) | 7.3 (5.8–9.1) | 6.8 (5.9–8.0) | 0.623 |
| HOMA-IR, GM (95% CI) | 1.5 (1.2–2.0) | 1.3 (1.0–1.5) | 0.190 |
| SBP (mmHg), GM (95% CI) | 124.2 (120.8–127.6) | 135.8 (131.8–140.0) | <0.001 |
| DBP (mmHg), GM (95% CI) | 84.0 (82.0–86.0) | 82.4 (80.4–84.5) | 0.281 |
| SBP≥140 mmHg or diastolic blood pressure≥90 mmHg, n (%) | 41 (39.0) | 38 (44.2) | 0.473 |
| SBP≥130 mmHg or diastolic blood pressure≥85 mmHg (or treatment for hypertension), n (%) | 54 (51.4) | 46 (53.5) | 0.777 |
| MetS, n (%) | 34 (35.1) | 21 (30.4) | 0.533 |
| Diabetes mellitus, n (%) | 6 (5.1) | 5 (5.9) | 0.808 |
| Angina, myocardial infarction or stroke, n (%) | 14 (10.8) | 8 (8.8) | 0.629 |
| Current smoker, n (%) | 16 (13.3) | 13 (14.0) | 0.892 |
| Physical activity, n (%) | |||
| Low | 35.0 (43) | 42.6 (29) | 0.575 |
| Moderate | 46.3 (57) | 41.2 (28) | |
| High | 18.7 (23) | 16.2 (11) | |
IQR=interquartile range; GM=geometric mean; WC=waist circumference; BMI=body mass index; TC=total cholesterol; HDL-C=high-density lipoprotein cholesterol; TG=triglycerides; SD=standard deviation; CI=confidence interval; Apo=apolipoprotein; FG=fasting glucose; HOMA-IR=Homeostasis Model Assessment of insulin resistance; SBP=systolic blood pressure; FI=fasting insulin; DBP=diastolic blood pressure; MetS=metabolic syndrome; WHR=waist-to-hip-ratio.
N within the groups may not be total 225 due to missing values.
p-values are obtained by Mann–Whitney test.
p-value is obtained by independent t-test.
p-values are obtained by ANCOVA, age adjusted.
p-values are obtained by Pearson Chi-Square test.
Impact of obesity indexes and ethnicitya on log10-transformed cardiometabolic risk factors in combined sample of women
| Models with BMI and ethnicity as independent variables | Models with WC and ethnicity as independent variables | Models with WHR and ethnicity as independent variables | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| BMI | Ethnicity | WC | Ethnicity | WHR | Ethnicity | |||||||
|
| ||||||||||||
| B (CI 95%) | p | B (CI 95%) | p | B (CI 95%) | p | B (CI 95%) | p | B (CI 95%) | p | B (CI 95%) | p | |
| SBP | 0.003 (0.001, 0.005) | 0.001 | −0.031 (−0.05, −0.012) | 0.002 | 0.001 (0.000, 0.002) | 0.005 | −0.038 (−0.058, −0.018) | <0.001 | 0.101 (−0.082, 0.284) | 0.278 | −0.031 (−0.052, −0.010) | 0.004 |
| TC | −0.002 (−0.005, 0.001) | 0.138 | 0.047 (0.017, 0.077) | 0.002 | −0.001 (−0.002, 0.000) | 0.137 | 0.046 (0.015, 0.078) | 0.004 | −0.124 (−0.404, 0.155) | 0.380 | 0.039 (0.006, 0.071) | 0.021 |
| HDL-C | −0.005 (−0.009, −0.001) | 0.019 | −0.014 (−0.056, 0.027) | 0.498 | −0.003 (−0.004, −0.001) | 0.006 | −0.014 (−0.057, 0.029) | 0.518 | −0.274 (−0.664, 0.115) | 0.166 | −0.027 (−0.072, 0.018) | 0.237 |
| TG | 0.010 (0.004, 0.016) | 0.001 | 0.061 (−0.003, 0.125) | 0.061 | 0.005 (0.002, 0.008) | <0.001 | 0.041 (−0.026, 0.108) | 0.231 | 1.046 (0.454, 1.638) | 0.001 | 0.077 (0.007, 0.146) | 0.031 |
| Apo B/Apo A–I | 0.006 (0.001, 0.011) | 0.029 | 0.049 (−0.007, 0.105) | 0.087 | 0.003 (0.000, 0.005) | 0.028 | 0.044 (−0.014, 0.102) | 0.137 | 0.297 (−0.216, 0.810) | 0.255 | 0.051 (−0.009, 0.111) | 0.096 |
| FG | 0.001 (−0.001, 0.004) | 0.186 | 0.070 (0.047, 0.094) | <0.001 | 0.001 (0.000, 0.002) | 0.040 | 0.067 (0.043, 0.091) | <0.001 | 0.185 (−0.028, 0.399) | 0.088 | 0.075 (0.050, 0.100) | <0.001 |
| FI | 0.026 (0.015, 0.038) | <0.001 | 0.173 (0.053, 0.294) | 0.005 | 0.012 (0.006, 0.017) | <0.001 | 0.127 (−0.004, 0.258) | 0.058 | 1.839 (0.761, 2.916) | 0.001 | 0.190 (0.054, 0.327) | 0.007 |
| HOMA–IR | 0.029 (0.016, 0.042) | <0.001 | 0.240 (0.108, 0.372) | 0.001 | 0.013 (0.007, 0.019) | <0.001 | 0.185 (0.040, 0.329) | 0.013 | 2.079 (0.899, 3.259) | 0.001 | 0.255 (0.106, 0.405) | 0.001 |
BMI=body mass index; WC=waist circumference; WHR=waist-to-hip ratio; CI=confidence interval; SBP=systolic blood pressure; TC=total cholesterol; HDL-C=high density lipoprotein cholesterol; TG=triglycerides; Apo=apolipoprotein; FG=fasting glucose; FI=fasting insulin; HOMA-IR index=Homeostasis Model Assessment of insulin resistance.
All the models included covariates age, smoking and physical activity.